Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carboplatin (paraplatin) (1 trial)
gemcitabine (gemzar) (1 trial)
naltrexone (revia) (1 trial)
vinblastine (velban) (1 trial)
Balcinrenone (1 trial)
dapagliflozin (farxiga) (1 trial)
Carcinoma, Transitional Cell (Phase 3)
Kidney Neoplasms (Phase 3)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Trials (2 total)
Trial APIs (6 total)